Human-on-a-chip models reveal CBD’s benefits and hidden risks
Investigating cannabidiol rescue of stress-induced cognitive impairment and metabolism-driven safety in Human-on-a-Chip® models.
AI Summary
This paper used human-based Human-on-a-Chip models to examine both the potential risks and possible benefits of cannabidiol (CBD). In a heart–liver system, the researchers compared CBD exposure with and without liver metabolism, as well as exposure to two CBD metabolites: 7-carboxy cannabidiol and 7-hydroxy cannabidiol. Metabolism produced significant changes compared with the parent compound alone, including alterations in cardiac beat frequency and contractile force, even when there was no significant evidence of cell death. This suggests that safety assessments should examine how the body transforms CBD—not just CBD itself.
A separate brain model used human stem-cell-derived cortical neurons to simulate stress-related dysfunction caused by cortisol. In this system, CBD produced a concentration-dependent rescue of impaired long-term potentiation (LTP), a cellular process associated with learning and memory. The effect was accompanied by changes in anandamide levels, suggesting possible involvement of the endocannabinoid system. These findings come from laboratory organ-on-a-chip models rather than human trials, so they do not establish that CBD improves cognition or is safe at particular doses for cannabis users. However, they demonstrate how human-based models may help investigate CBD’s brain effects and metabolism-related cardiac risks before clinical testing.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More CBD research papers you might find interesting.
A lab method measures 17 cannabinoids across five hemp product types
CBD showed limited adaptive-functioning differences versus placebo in boys…
NMR profiling finds THC predominates in Moroccan beldia extracts
Explore More Research
Stay informed about the latest cannabis science.